Fifth Harmony taking a break to pursue solo projects
Updated | By Tamlyn Canham
The girls of Fifth Harmony will not be making any new music in 2018.
One year after losing a band member, Fith Harmony will be taking an "indefinite" hiatus.
The girl group announced the news on Monday, saying Normani Kordei, Ally Brooke, Dinah Jane, and Lauren Jauregui will be using the time to pursue solo careers.
"After six years going hard, non-stop, we also realized that in order to stay authentic to ourselves and to you, we do need to take some time for now to go on a hiatus from Fifth Harmony in order to pursue solo endeavors," a statement on their official Twitter account read.
The group was formed on the US version of 'X-Factor'. They finished in third place.
The girls have had a successful career since then, with hits such as 'Work from Home', 'Worth It', 'Sledgehammer', 'Worth It', and 'All in my Head'.
But things took a turn for the worse when fan favourite Camila Cabello announced in December 2016 that she was leaving.
ALSO READ: Fifth Harmony explain why they 'dissed' Camilla Cabello
While Camila's career soared, thanks to hits like 'Havana' and 'Never be the Same' - which is currently at number two on the Coca-Cola Top 40, her former group members struggled to achieve the level of success they once enjoyed.
ALSO READ: Fifth Harmony drops first song without Camilla Cabello
While Normani, Ally, Dinah, and Lauren have millions of fans between them, only time will tell if their solo careers will be successful.
— Fifth Harmony (@FifthHarmony) March 19, 2018
ALSO READ: N.E.R.D drops new 'Lemon' remix featuring Drake
Carol Ofori and Ricky take you through 40 of the planet’s hottest songs in our weekly chart show, the Coca-Cola Top 40, on Saturdays from 10am to 2pm.
Show's Stories
-
Happy World Hello Day! The many ways we say 'hello' in KZN
We agree that Adele and Lionel Richie did it well, but 'Hello' just does...
Danny Guselli 6 hours ago -
Yaz Plus: Here’s why the contraceptive was recalled
Bayer recalled Yaz Plus pills over a mix-up risking efficacy. Patients c...
Stacey & J Sbu 6 hours ago